As a result of the relentless pace of today’s drug discovery, pharmaceutical companies face ever-increasing throughput demands for compound screening and lead identification. Many pharmaceutical companies have active screening libraries that contain hundreds of thousands or millions of compounds, and effective and reliable management of these samples is critical to drug development processes.
